Four DACH startups awarded through the Start-up Rescue Instrument

EIT Health has awarded 11 start-ups in Europe with the new Start-up Rescue Instrument, with the goal of supporting their  business continuity in response to the disruptions caused by the COVID-19 pandemic. Four of them come from the DACH region: Volumina Medical, Portabiles HealthCare Technologies, Hemotune and Allcyte.

Part of the EIT Crisis Response Initiative, the EIT Health Start-up Rescue Instrument was created to alleviate the economic shock posed by the COVID-19 pandemic. The new instrument is aimed to support highly innovative ventures by increasing investor firepower and bridging the fundraising gap of start-ups in Series A, Series B and bridge-financing rounds. In addition to providing a boost to bridge financing rounds, EIT Health will offer selected start-ups a strong network of partners and introduce them to other opportunities in the EIT Health portfolio programmes.

Following the evaluation process, a total of 11 start-ups were selected to receive up to €500,000, and use the investment to further develop their solutions in cancer, infectious diseases, wound and joint care, medical imaging, and cardiovascular disease.

The selected start-ups from the DACH region:

Allcyte GmbH (Austria): Allcyte is a biotech start-up company focused on functional drug testing in primary human material. With their Pharmacoscopy high-content imaging platform, Allcyte is set on a mission to bring the next generation of personalised medicine to cancer patients and treating physicians, and support pharmaceutical companies to focus their drug development efforts on the right molecules in the right indications.

hemotune AG (Switzerland): hemotune AG is developping a revolutionary medical device for blood purification that combines cutting-edge scientific results from biomedicine and nanotechnology. Their first development candidate focuses on sepsis.

Portabiles HealthCare Technologies (Germany): Portabiles HealthCare Technologies develops high-precision solutions for medical gait analysis – for better therapies and better quality of life for patients with movement disorders.

Volumina Medical (Switzerland): Volumina Medical addresses the problem of natural repair of 3D soft tissue by developing highly innovative tissue reconstruction technologies for the market of reconstructive and plastic surgery.

The full list of selected start-ups is available here.

Congratulations to the teams!